Trial Outcomes & Findings for High Pain Intervention in Cesarean Sections (NCT NCT01298778)

NCT ID: NCT01298778

Last Updated: 2018-09-10

Results Overview

to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces acute post-delivery pain (24 hour evoked pain post delivery). The scale utilized was a 100mm sliding VAS, where 0mm=no pain up to 100mm-worst pain imaginable.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

69 participants

Primary outcome timeframe

24 hour

Results posted on

2018-09-10

Participant Flow

Participants were approached during the pre-anesthesia evaluation regarding their interest in the study. Once consent was signed, subjects completed their pre-surgery questionnaires. On the day of surgery, I/E criteria were re-reviewed for confirmed enrollment for study.A total of 74 were consented with 69 randomized, with 60 completing the study.

Participant milestones

Participant milestones
Measure
Standard of Care
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Overall Study
STARTED
33
36
Overall Study
COMPLETED
30
30
Overall Study
NOT COMPLETED
3
6

Reasons for withdrawal

Reasons for withdrawal
Measure
Standard of Care
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Overall Study
Lost to Follow-up
2
3
Overall Study
Incorrect use of VAS
1
0
Overall Study
Withdrawal by Subject
0
1
Overall Study
Protocol Violation
0
1
Overall Study
not meet inclusion/exclusion criteria
0
1

Baseline Characteristics

High Pain Intervention in Cesarean Sections

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Total
n=60 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
30 Participants
n=5 Participants
30 Participants
n=7 Participants
60 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Sex: Female, Male
Female
30 Participants
n=5 Participants
30 Participants
n=7 Participants
60 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Region of Enrollment
United States
30 participants
n=5 Participants
30 participants
n=7 Participants
60 participants
n=5 Participants
Height-cm
163 cm
STANDARD_DEVIATION 6 • n=5 Participants
164 cm
STANDARD_DEVIATION 6 • n=7 Participants
163.3 cm
STANDARD_DEVIATION 6 • n=5 Participants
Weight-kg
88 kg
STANDARD_DEVIATION 17 • n=5 Participants
92 kg
STANDARD_DEVIATION 19 • n=7 Participants
89.7 kg
STANDARD_DEVIATION 17.7 • n=5 Participants
Gestational Age-weeks
39 weeks gestation
STANDARD_DEVIATION 0.3 • n=5 Participants
39 weeks gestation
STANDARD_DEVIATION 0.7 • n=7 Participants
39 weeks gestation
STANDARD_DEVIATION 0.5 • n=5 Participants
Parity
1 number previous deliveries
n=5 Participants
1 number previous deliveries
n=7 Participants
1 number previous deliveries
n=5 Participants
Previous Cesarean Section
27 Participants
n=5 Participants
24 Participants
n=7 Participants
51 Participants
n=5 Participants
ASA class
2 units on a scale
n=5 Participants
2 units on a scale
n=7 Participants
2 units on a scale
n=5 Participants

PRIMARY outcome

Timeframe: 24 hour

to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces acute post-delivery pain (24 hour evoked pain post delivery). The scale utilized was a 100mm sliding VAS, where 0mm=no pain up to 100mm-worst pain imaginable.

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Severity of Acute Pain
46 mm
Standard Deviation 25
31 mm
Standard Deviation 17

SECONDARY outcome

Timeframe: 2 months

to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces persistent pain up to 2 months post delivery.

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Incidence of Persistent Pain
13 percentage of participants
10 percentage of participants

SECONDARY outcome

Timeframe: 24 hour

resting pain, worst pain

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Pain
resting pain score over 24 hrs
19 units on a scale, 0 -none, 100-worst
Interval 0.0 to 33.0
4 units on a scale, 0 -none, 100-worst
Interval 0.0 to 10.0
Pain
worst pain score over 24 hrs
69 units on a scale, 0 -none, 100-worst
Interval 49.0 to 77.0
62 units on a scale, 0 -none, 100-worst
Interval 42.0 to 70.0

SECONDARY outcome

Timeframe: 24 hour

total amount of analgesic consumption

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Analgesic Consumption
IV PCA morphine
15 mg
Interval 11.0 to 32.0
15 mg
Interval 11.0 to 29.0
Analgesic Consumption
total 24 hr opioid use
21 mg
Interval 11.0 to 37.0
15 mg
Interval 13.0 to 33.0

SECONDARY outcome

Timeframe: 2 months

to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces postpartum depression up to 2 months post delivery.

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Incidence of Depression
3 Participants
4 Participants

SECONDARY outcome

Timeframe: 24 hours

Population: VAS pain score of 0=no pain at all up to 100 being worst pain imaginable.

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Average Pain Over 24 Hours
37 units on a scale
Standard Deviation 19
23 units on a scale
Standard Deviation 14

OTHER_PRE_SPECIFIED outcome

Timeframe: 24 hours

Population: percentage of patients with pruritis requiring treatment.

side effects-percentage of subjects requiring treatment

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Pruritus
15 Participants
21 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 24hours

Population: percentage of patients reporting emetic symptoms requiring treatment

side effect potential with the increased dose of duramorph-percentage experiencing such symptoms

Outcome measures

Outcome measures
Measure
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care. Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
Emetic Symptoms
16 Participants
18 Participants

Adverse Events

Standard of Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Acetaminophen and Increased Dose of Duramorph

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jessica Booth

Wake Forest School of Medicine

Phone: 336-718-8278

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place